Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gina B Scott

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
The Biochemical Journal|August 14, 2010
Identification of the BCL2/adenovirus E1B-19K protein-interacting protein 2 (BNIP-2) as a granzyme B target during human natural killer cell-mediated killingGina B Scott, Paul A Bowles, Erica B Wilson, et al.
Molecular Therapy Oncolytics|April 20, 2023
Efficacy of coxsackievirus A21 against drug-resistant neoplastic B cellsMatthew Holmes, Gina B Scott, Samuel Heaton, et al.
Molecular Immunology|December 25, 2013
Blocking oncogenic RAS enhances tumour cell surface MHC class I expression but does not alter susceptibility to cytotoxic lymphocytesJehan J El-Jawhari, Yasser M El-Sherbiny, Gina B Scott, et al.
Carcinogenesis|January 29, 2011
In vitro functional effects of XPC gene rare variants from bladder cancer patientsBoling Qiao, Abdul-Haq Ansari, Gina B Scott, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 5, 2019
Potentiating Oncolytic Virus-Induced Immune-Mediated Tumor Cell Killing Using Histone Deacetylase InhibitionVictoria A Jennings, Gina B Scott, Ailsa M S Rose, et al.
Journal for Immunotherapy of Cancer|March 20, 2021
Reovirus-induced cell-mediated immunity for the treatment of multiple myeloma within the resistant bone marrow nicheLouise M E Müller, Gemma Migneco, Gina B Scott, et al.
Journal for Immunotherapy of Cancer|July 3, 2019
Plasmacytoid dendritic cells orchestrate innate and adaptive anti-tumor immunity induced by oncolytic coxsackievirus A21Louise M E Müller, Matthew Holmes, Joanne L Michael, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
The Biochemical Journal|August 14, 2010
Identification of the BCL2/adenovirus E1B-19K protein-interacting protein 2 (BNIP-2) as a granzyme B target during human natural killer cell-mediated killingGina B Scott, Paul A Bowles, Erica B Wilson, et al.
Molecular Therapy Oncolytics|April 20, 2023
Efficacy of coxsackievirus A21 against drug-resistant neoplastic B cellsMatthew Holmes, Gina B Scott, Samuel Heaton, et al.
Molecular Immunology|December 25, 2013
Blocking oncogenic RAS enhances tumour cell surface MHC class I expression but does not alter susceptibility to cytotoxic lymphocytesJehan J El-Jawhari, Yasser M El-Sherbiny, Gina B Scott, et al.
Carcinogenesis|January 29, 2011
In vitro functional effects of XPC gene rare variants from bladder cancer patientsBoling Qiao, Abdul-Haq Ansari, Gina B Scott, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 5, 2019
Potentiating Oncolytic Virus-Induced Immune-Mediated Tumor Cell Killing Using Histone Deacetylase InhibitionVictoria A Jennings, Gina B Scott, Ailsa M S Rose, et al.
Journal for Immunotherapy of Cancer|March 20, 2021
Reovirus-induced cell-mediated immunity for the treatment of multiple myeloma within the resistant bone marrow nicheLouise M E Müller, Gemma Migneco, Gina B Scott, et al.
Journal for Immunotherapy of Cancer|July 3, 2019
Plasmacytoid dendritic cells orchestrate innate and adaptive anti-tumor immunity induced by oncolytic coxsackievirus A21Louise M E Müller, Matthew Holmes, Joanne L Michael, et al.
Pageof 2